Moneycontrol PRO
HomeNewsBusinessMarketsEmami shares gain as Q2 earnings beat estimates: Should you buy the stock?

Emami shares gain as Q2 earnings beat estimates: Should you buy the stock?

Emami's future growth will be driven by investments in new brands, double-digit growth CAGR in the international market, rural distribution expansion and recovery in the rural market, said Motilal Oswal.

November 07, 2023 / 09:27 IST
Emami stock has risen around 21 percent, outperforming Nifty

Emami stock has risen around 21 percent, outperforming Nifty

Emami shares opened with gains on November 7, a day after the company beat the estimates for the September quarter earnings. Although its net profit fell 3 percent on-year to Rs 178.5 crore, dented by lower other incomes, the FMCG company showed up a healthy operating performance with its consolidated revenue from operations rising 6 percent to Rs 864.5 crore.

Analysts remain largely positive on Emami, considering a gradual rural revival in sales, inexpensive valuations, improving revenue performance, rural distribution expansion, and increased ad spending.

Outlook

"Emami's Q2 FY24 numbers were an all-around beat to our estimate led by better-than-expected growth in both modern trade (MT) and e-commerce channel," said Prabhudas Lilladher in its first cut. The company's performance in the second half of FY24 will be a function of winter progress and success of new products and moderate raw material prices, it added.

Also Read | Emami Q2: Net profit falls marginally to Rs 179.99 crore, revenue rises 6.23%

Low raw material costs drove a 300-bps EBITDA margin expansion. Its domestic business grew 4 percent and international business growth came in at 12 percent for the quarter under review. According to HSBC, Emami's international business is delivering consistent results, while growth visibility remains weak in the domestic business amid muted rural demand.

Should you buy, hold or sell the stock?

While HSBC has a 'hold' call on the Emami stock with a target price of Rs 485 per share, brokerage firm Prabhudas Lilladher has put an 'accumulate' rating on the stock.

Analysts at Motilal Oswal believe that Emami's future growth will be driven by investments in new brands, double-digit CAGR in the international market, rural distribution expansion and recovery in the rural market (over 50 percent sales).

There is also margin improvement scope in the e-commerce and MT channels, it said. The domestic brokerage believes that valuations are inexpensive at 19.5x FY25 EPS; hence it reiterated its 'buy' rating on the stock with a target price of Rs 640 per share.

Also Read | Buzzing Stocks: Nykaa, HPCL, Bajaj Finance, Emami, NHPC, Gland Pharma, others in news

Emami shares ended 2.3 percent higher at Rs 520.70 on the National Stock Exchange (NSE) in the previous session. So far in 2023, the stock has risen around 21 percent, outperforming the benchmark Nifty.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

first published: Nov 7, 2023 08:42 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347